vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and Life360, Inc. (LIF). Click either name above to swap in a different company.
BALCHEM CORP is the larger business by last-quarter revenue ($263.6M vs $146.0M, roughly 1.8× Life360, Inc.). Life360, Inc. runs the higher net margin — 88.8% vs 14.9%, a 73.9% gap on every dollar of revenue. On growth, Life360, Inc. posted the faster year-over-year revenue change (26.4% vs 9.8%). Over the past eight quarters, Life360, Inc.'s revenue compounded faster (36.6% CAGR vs 4.9%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
Life360, Inc. develops family-focused safety and connectivity platforms. Core offerings include real-time location sharing, emergency alerts, driving behavior analysis tools and identity theft protection. It serves consumer markets across North America, Europe and Asia-Pacific, with most revenue from tiered premium subscription plans.
BCPC vs LIF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $263.6M | $146.0M |
| Net Profit | $39.2M | $129.7M |
| Gross Margin | 35.6% | 75.1% |
| Operating Margin | 19.8% | 6.1% |
| Net Margin | 14.9% | 88.8% |
| Revenue YoY | 9.8% | 26.4% |
| Net Profit YoY | 16.8% | 1425.9% |
| EPS (diluted) | $1.21 | $1.53 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $263.6M | $146.0M | ||
| Q3 25 | $267.6M | $124.5M | ||
| Q2 25 | $255.5M | $115.4M | ||
| Q1 25 | $250.5M | $103.6M | ||
| Q4 24 | $240.0M | $115.5M | ||
| Q3 24 | $239.9M | $92.9M | ||
| Q2 24 | $234.1M | $84.9M | ||
| Q1 24 | $239.7M | $78.2M |
| Q4 25 | $39.2M | $129.7M | ||
| Q3 25 | $40.3M | $9.8M | ||
| Q2 25 | $38.3M | $7.0M | ||
| Q1 25 | $37.1M | $4.4M | ||
| Q4 24 | $33.6M | $8.5M | ||
| Q3 24 | $33.8M | $7.7M | ||
| Q2 24 | $32.1M | $-11.0M | ||
| Q1 24 | $29.0M | $-9.8M |
| Q4 25 | 35.6% | 75.1% | ||
| Q3 25 | 35.7% | 78.0% | ||
| Q2 25 | 36.4% | 78.4% | ||
| Q1 25 | 35.2% | 80.6% | ||
| Q4 24 | 36.0% | 74.0% | ||
| Q3 24 | 35.6% | 75.4% | ||
| Q2 24 | 35.5% | 75.0% | ||
| Q1 24 | 34.0% | 76.7% |
| Q4 25 | 19.8% | 6.1% | ||
| Q3 25 | 20.4% | 4.6% | ||
| Q2 25 | 20.1% | 1.7% | ||
| Q1 25 | 20.4% | 2.1% | ||
| Q4 24 | 19.8% | 4.9% | ||
| Q3 24 | 20.0% | -5.3% | ||
| Q2 24 | 19.6% | -2.8% | ||
| Q1 24 | 17.4% | -8.2% |
| Q4 25 | 14.9% | 88.8% | ||
| Q3 25 | 15.1% | 7.9% | ||
| Q2 25 | 15.0% | 6.1% | ||
| Q1 25 | 14.8% | 4.2% | ||
| Q4 24 | 14.0% | 7.4% | ||
| Q3 24 | 14.1% | 8.3% | ||
| Q2 24 | 13.7% | -12.9% | ||
| Q1 24 | 12.1% | -12.5% |
| Q4 25 | $1.21 | $1.53 | ||
| Q3 25 | $1.24 | $0.11 | ||
| Q2 25 | $1.17 | $0.08 | ||
| Q1 25 | $1.13 | $0.05 | ||
| Q4 24 | $1.03 | $0.14 | ||
| Q3 24 | $1.03 | $0.09 | ||
| Q2 24 | $0.98 | $-0.15 | ||
| Q1 24 | $0.89 | $-0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $74.6M | $494.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3B | $548.2M |
| Total Assets | $1.7B | $959.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $494.3M | ||
| Q3 25 | $65.1M | $455.7M | ||
| Q2 25 | $65.4M | $432.7M | ||
| Q1 25 | $49.9M | $168.9M | ||
| Q4 24 | $49.5M | $159.2M | ||
| Q3 24 | $73.7M | $159.0M | ||
| Q2 24 | $63.7M | $160.8M | ||
| Q1 24 | $60.3M | $73.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $5.2M |
| Q4 25 | $1.3B | $548.2M | ||
| Q3 25 | $1.3B | $391.4M | ||
| Q2 25 | $1.3B | $366.7M | ||
| Q1 25 | $1.2B | $376.3M | ||
| Q4 24 | $1.1B | $358.5M | ||
| Q3 24 | $1.2B | $339.7M | ||
| Q2 24 | $1.1B | $326.7M | ||
| Q1 24 | $1.1B | $239.8M |
| Q4 25 | $1.7B | $959.7M | ||
| Q3 25 | $1.7B | $787.5M | ||
| Q2 25 | $1.7B | $753.6M | ||
| Q1 25 | $1.6B | $455.4M | ||
| Q4 24 | $1.6B | $441.6M | ||
| Q3 24 | $1.6B | $427.4M | ||
| Q2 24 | $1.6B | $405.9M | ||
| Q1 24 | $1.6B | $318.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $67.3M | $36.8M |
| Free Cash FlowOCF − Capex | — | $36.6M |
| FCF MarginFCF / Revenue | — | 25.1% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | 1.72× | 0.28× |
| TTM Free Cash FlowTrailing 4 quarters | — | $86.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $67.3M | $36.8M | ||
| Q3 25 | $65.6M | $26.4M | ||
| Q2 25 | $47.3M | $13.3M | ||
| Q1 25 | $36.5M | $12.1M | ||
| Q4 24 | $52.3M | $12.3M | ||
| Q3 24 | $51.3M | $6.3M | ||
| Q2 24 | $45.0M | $3.3M | ||
| Q1 24 | $33.4M | $10.7M |
| Q4 25 | — | $36.6M | ||
| Q3 25 | — | $25.6M | ||
| Q2 25 | — | $12.7M | ||
| Q1 25 | — | $11.9M | ||
| Q4 24 | — | $11.2M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $3.2M | ||
| Q1 24 | — | — |
| Q4 25 | — | 25.1% | ||
| Q3 25 | — | 20.6% | ||
| Q2 25 | — | 11.0% | ||
| Q1 25 | — | 11.5% | ||
| Q4 24 | — | 9.7% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 3.8% | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 1.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | 1.72× | 0.28× | ||
| Q3 25 | 1.63× | 2.70× | ||
| Q2 25 | 1.23× | 1.90× | ||
| Q1 25 | 0.98× | 2.75× | ||
| Q4 24 | 1.56× | 1.45× | ||
| Q3 24 | 1.52× | 0.83× | ||
| Q2 24 | 1.40× | — | ||
| Q1 24 | 1.15× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
LIF
Segment breakdown not available.
